Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Transplantation and Cellular Therapy|April 12, 2024
Recruitment and Retention of Hematopoietic Cell Transplantation and Cellular Therapy Physicians: A Report from the ASTCT Talent Acquisition Task ForceAkshay Sharma, Agnieszka Czechowicz, Melissa Mavers, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2003
Primary amyloidosis patients with significant organ dysfunction tolerate autologous transplantation after conditioning with single-dose total body irradiation alone: a feasibility studyWilliam Blum, Hanna Khoury, H-S Lin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2020
Development of [89Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myelomaAnchal Ghai, Alexander Zheleznyak, Matt Mixdorf, et al.
Leukemia & Lymphoma|July 16, 2009
Advances in mobilization for the optimization of autologous stem cell transplantationJulie M Vose, Anthony D Ho, Bertrand Coiffier, et al.
Blood|August 17, 2006
Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100Rebecca M Shepherd, Benjamin J Capoccia, Steven M Devine, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 31, 2016
Phase II Study of Propylene Glycol-Free Melphalan Combined with Carmustine, Etoposide, and Cytarabine for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell TransplantationAmanda F Cashen, Theresa Fletcher, Connie Ceriotti, et al.
EJNMMI Research|September 29, 2021
In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [18F]FDG and [64Cu]Cu-LLP2A PETAnchal Ghai, Nikki Fettig, Francesca Fontana, et al.
Annals of Hematology|May 4, 2011
Phase II study of the histone deacetylase inhibitor belinostat (PXD101) for the treatment of myelodysplastic syndrome (MDS)Amanda Cashen, Mark Juckett, Alcee Jumonville, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 7, 2017
Phase I/II Study of Intravenous Plerixafor Added to a Mobilization Regimen of Granulocyte Colony-Stimulating Factor in Lymphoma Patients Undergoing Autologous Stem Cell CollectionAmanda F Cashen, Michael Rettig, Feng Gao, et al.
Leukemia & Lymphoma|June 10, 2017
Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I studySagun Goyal, Eunhye Oak, Jingqin Luo, et al.
Pageof 5